Cargando…
A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression
BACKGROUND AND OBJECTIVE: A recent striking advance in the treatment of depression has been the finding of rapid antidepressant effects in over 70% of patients with treatment-resistant depression (TRD) using ketamine. However, the potential risk of addiction may limit its clinical use. Recent resear...
Autores principales: | Jiang, Jiajun, Wang, Zheng, Dong, YiYan, Yang, Yan, Ng, Chee H., Ma, Shuangshuang, Xu, Yi, Hu, Hailan, Hu, Shaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709087/ https://www.ncbi.nlm.nih.gov/pubmed/31374046 http://dx.doi.org/10.1097/MD.0000000000016674 |
Ejemplares similares
-
Ethosuximide for Essential Tremor: An Open-Label Trial
por: Gironell, Alexandre, et al.
Publicado: (2016) -
Otoprotective effects of ethosuximide in NOD/LtJ mice with age-related hearing loss
por: Sang, Lu, et al.
Publicado: (2017) -
The Anticonvulsant Ethosuximide Disrupts Sensory Function to Extend C. elegans Lifespan
por: Collins, James J., et al.
Publicado: (2008) -
Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model
por: Nygaard, Haakon B, et al.
Publicado: (2015) -
Ethosuximide inhibits acute histamine- and chloroquine-induced scratching behavior in mice
por: Gadotti, Vinicius M., et al.
Publicado: (2021)